A Phase II Study in Adult Patients With Moderate to Severe Atopic Dermatitis
Clinical trial NCT04162899 · COMPLETED
Trial details
- NCT number
- NCT04162899
- Sponsor
- Reistone Biopharma Company Limited
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-06
- Primary completion
- 2020-08-21
- Enrollment
- 105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.